Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs Twice Daily Dosing of Flomax-A 3 Month Retrospective Efficacy Analysis

NCT00264017 is registered in ClinicalTrials.gov with Dattoli Cancer Center and Brachytherapy Research Institute as lead sponsor.

NCT NCT00264017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00264017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs Twice Daily Dosing of Flomax-A 3 Month Retrospective Efficacy Analysis
Lead sponsor
Dattoli Cancer Center and Brachytherapy Research Institute
Phase
Observational
Overall status
Completed
Start date
November 30, 2005
Completion date
November 30, 2005
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer patients undergoing external radiation and seed implantation